Eris Lifesciences Limited IPO – GMP, Review, Share Price, Subscription, and Details

1.Eris Lifesciences Limited IPO Overview

The initial public offering (IPO) of Eris Lifesciences Limited is a public issue under the Mainboard board. The subscription window is scheduled to open on Jun 16, 2017 and close on Jun 20, 2017, with the price band fixed at ₹600–603 per equity share.

2.Issue Details at a Glance

3.Bidding, Allotment & Listing Timeline

• Bidding opens: Jun 16, 2017
• Bidding closes: Jun 20, 2017
• Allotment date: TBA
• Listing date: 2017-06-29
• Minimum investment: TBA

4.Eris Lifesciences Limited IPO GMP Today

No grey market premium has been recorded for Eris Lifesciences Limited yet. GMP is an informal, unregulated indicator of listing-day sentiment and is not published by any exchange.

5.How to Apply for Eris Lifesciences Limited IPO

1. 1Open IPOGMPTracker or use your broker's app or net banking ASBA facility.
2. 2Search for "Eris Lifesciences Limited IPO" and select it from the list of current issues.
3. 3Choose your demat account and enter your bid quantity in multiples of the —-share lot, at a price within the ₹600–603 band (or bid at cut-off, if eligible).
4. 4Submit the application and approve the UPI mandate request when it arrives — funds stay blocked in your account and are debited only on allotment.

Allotment is expected to be finalised around TBA, with listing tentatively scheduled for 2017-06-29 on BSE and NSE. Once finalised, check your status on the Eris Lifesciences Limited IPO allotment status page.

6.How to Track Subscription & Allotment

• Live subscription: Track QIB, NII and retail bidding on the IPO subscription status page
• Allotment status: Check your application on the IPO allotment status page
• Full IPO details: See dates, lot size, reservation and financials on the Eris Lifesciences Limited IPO page
• More issues: Browse current IPOs, upcoming IPOs and the IPO event calendar

7.Conclusion

Eris Lifesciences Limited opens on Jun 16, 2017 and closes on Jun 20, 2017 at ₹600–603 per share. Read the offer documents in full and consult a qualified adviser before applying — nothing on this page is investment advice.